Axa S.A. Denali Therapeutics Inc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Axa S.A. holds 344,883 shares of DNLI stock, worth $8.45 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

344,883

Previous 344,785 0.03%

Holding current value

$8.45 Million

Previous $8.01 Million 25.5%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.96 - $31.05 $2,054 - $3,042	98 Added 0.03%	344,883 $10 Million
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $239,704 - $372,054	-16,023 Reduced 4.44%	344,785 $8.01 Million
Q1 2024 May 15, 2024	BUY	$15.83 - $23.35 $3,371 - $4,973	213 Added 0.06%	360,808 $7.4 Million
Q4 2023 Jul 16, 2024	SELL	$16.2 - $23.18 $3,450 - $4,937	-213 Reduced 0.06%	360,595 $7.74 Million
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $98,269 - $140,609	6,066 Added 1.71%	360,595 $7.74 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $79,487 - $116,245	-3,853 Reduced 1.08%	354,529 $7.31 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $1.62 Million - $2.28 Million	69,140 Added 23.9%	358,382 $10.6 Million
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $14,854 - $22,150	-678 Reduced 0.23%	289,242 $6.66 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $1.08 Million - $1.4 Million	41,148 Added 16.54%	289,920 $8.06 Million
Q3 2022 Feb 14, 2023	BUY	$25.97 - $38.53 $28,073 - $41,650	1,081 Added 0.44%	248,772 $7.63 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $28,073 - $41,650	1,081 Added 0.44%	248,772 $7.64 Million
Q2 2022 Feb 14, 2023	BUY	$20.88 - $35.19 $983,928 - $1.66 Million	47,123 Added 23.49%	247,691 $7.29 Million
Q2 2022 Aug 15, 2022	BUY	$20.88 - $35.19 $983,928 - $1.66 Million	47,123 Added 23.49%	247,691 $7.29 Million
Q1 2022 Feb 14, 2023	SELL	$29.0 - $47.27 $1.4 Million - $2.28 Million	-48,204 Reduced 19.38%	200,568 $6.45 Million
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $565,442 - $921,670	-19,498 Reduced 8.86%	200,568 $6.45 Million
Q4 2021 Feb 14, 2022	BUY	$42.59 - $55.02 $787,318 - $1.02 Million	18,486 Added 9.17%	220,066 $9.82 Million
Q3 2021 Nov 15, 2021	BUY	$48.48 - $78.23 $915,302 - $1.48 Million	18,880 Added 10.33%	201,580 $10.2 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $287,816 - $448,833	5,722 Added 3.23%	182,700 $14.3 Million
Q1 2021 May 14, 2021	BUY	$53.8 - $81.53 $1.01 Million - $1.53 Million	18,788 Added 11.88%	176,978 $10.1 Million
Q4 2020 Feb 12, 2021	SELL	$36.89 - $93.56 $2.39 Million - $6.07 Million	-64,881 Reduced 29.09%	158,190 $13.3 Million
Q3 2020 Nov 13, 2020	SELL	$23.13 - $38.84 $49,012 - $82,301	-2,119 Reduced 0.94%	223,071 $7.99 Million
Q2 2020 Aug 14, 2020	BUY	$16.01 - $28.82 $596,020 - $1.07 Million	37,228 Added 19.81%	225,190 $5.45 Million
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $2.67 Million - $5.26 Million	187,962 New	187,962 $3.29 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.29B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account